Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system.
Knerr S, Guo B, Wernli KJ, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Liles EG, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Wilfond BS, Devine B, Goddard KAB. Knerr S, et al. Among authors: wernli kj. Breast Cancer Res Treat. 2023 Oct;201(3):461-470. doi: 10.1007/s10549-023-07007-w. Epub 2023 Jul 20. Breast Cancer Res Treat. 2023. PMID: 37470892
Women's Breast Cancer Screening Confidence by Screening Modality and Breast Density: A Breast Cancer Surveillance Consortium Survey Study.
Tosteson ANA, Schifferdecker KE, Smith RE, Wernli KJ, Zhao W, Kaplan CP, Buist DSM, Henderson LM, Sprague BL, Onega T, Budesky J, Jackson-Nefertiti G, Johnson D, Miglioretti DL, Kerlikowske K. Tosteson ANA, et al. Among authors: wernli kj. J Womens Health (Larchmt). 2022 Nov;31(11):1547-1556. doi: 10.1089/jwh.2021.0649. J Womens Health (Larchmt). 2022. PMID: 36356184 Free PMC article.
Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors.
Su YR, Buist DSM, Lee JM, Ichikawa L, Miglioretti DL, Bowles EJA, Wernli KJ, Kerlikowske K, Tosteson A, Lowry KP, Henderson LM, Sprague BL, Hubbard RA. Su YR, et al. Among authors: wernli kj. Cancer Epidemiol Biomarkers Prev. 2023 Apr 3;32(4):561-571. doi: 10.1158/1055-9965.EPI-22-0677. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36697364 Free PMC article.
Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young Adults.
Nichols HB, Wernli KJ, Chawla N, O'Meara ES, Gray MF, Green LE, Baggett CD, Casperson M, Chao C, Jones SMW, Kirchhoff AC, Kuo TM, Lee C, Malogolowkin M, Quesenberry CP, Ruddy KJ, Wun T, Zebrack B, Chubak J, Hahn EE, Keegan THM, Kushi LH. Nichols HB, et al. Among authors: wernli kj. Curr Epidemiol Rep. 2023 Sep;10(3):115-124. doi: 10.1007/s40471-022-00286-9. Epub 2022 Mar 29. Curr Epidemiol Rep. 2023. PMID: 37700859
Hormone therapy and ovarian cancer: incidence and survival.
Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Wernli KJ, et al. Cancer Causes Control. 2008 Aug;19(6):605-13. doi: 10.1007/s10552-008-9125-x. Epub 2008 Feb 9. Cancer Causes Control. 2008. PMID: 18264784 Free PMC article.
Antidepressant medication use and breast cancer risk.
Wernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA. Wernli KJ, et al. Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):284-90. doi: 10.1002/pds.1719. Pharmacoepidemiol Drug Saf. 2009. PMID: 19226540 Free PMC article.
158 results